palbociclib
pfizer,medsir
['palmira', 'mbc', 'breast', 'palbociclib', 'palbo']
second-line endocrine therapy (et) with or without palbociclib (p) maintenance in patients (pts) with hormone receptor-positive (hr[+])/human epidermal growth factor receptor 2-negative (her2[-]) advanced breast cancer (abc): palmira trial. #mbc #asco23 